Annual Total Liabilities
$948.74 M
+$470.35 M+98.32%
September 30, 2024
Summary
- As of February 7, 2025, ARWR annual total liabilities is $948.74 million, with the most recent change of +$470.35 million (+98.32%) on September 30, 2024.
- During the last 3 years, ARWR annual total liabilities has risen by +$647.41 million (+214.85%).
- ARWR annual total liabilities is now at all-time high.
Performance
ARWR Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$948.74 M
+$403.95 M+74.15%
September 30, 2024
Summary
- As of February 7, 2025, ARWR quarterly total liabilities is $948.74 million, with the most recent change of +$403.95 million (+74.15%) on September 30, 2024.
- Over the past year, ARWR quarterly total liabilities has increased by +$488.99 million (+106.36%).
- ARWR quarterly total liabilities is now at all-time high.
Performance
ARWR Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
ARWR Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +98.3% | +106.4% |
| 3 y3 years | +214.8% | +214.8% |
| 5 y5 years | +796.6% | +214.8% |
ARWR Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +246.8% | at high | +277.5% |
| 5 y | 5-year | at high | +1462.3% | at high | +2018.7% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Arrowhead Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | $948.74 M(+98.3%) | $948.74 M(+74.1%) |
| Jun 2024 | - | $544.78 M(+18.5%) |
| Mar 2024 | - | $459.75 M(+1.6%) |
| Dec 2023 | - | $452.57 M(-5.4%) |
| Sep 2023 | $478.39 M(+74.9%) | $478.39 M(+15.6%) |
| Jun 2023 | - | $413.87 M(-2.9%) |
| Mar 2023 | - | $426.20 M(-13.9%) |
| Dec 2022 | - | $495.12 M(+81.0%) |
| Sep 2022 | $273.60 M(-9.2%) | $273.60 M(-1.4%) |
| Jun 2022 | - | $277.61 M(+10.5%) |
| Mar 2022 | - | $251.31 M(-5.5%) |
| Dec 2021 | - | $265.98 M(-11.7%) |
| Sep 2021 | $301.33 M(+396.2%) | $301.33 M(+1.1%) |
| Jun 2021 | - | $298.04 M(-4.2%) |
| Mar 2021 | - | $311.25 M(+595.1%) |
| Dec 2020 | - | $44.78 M(-26.3%) |
| Sep 2020 | $60.73 M(-42.6%) | $60.73 M(-3.8%) |
| Jun 2020 | - | $63.14 M(-6.5%) |
| Mar 2020 | - | $67.51 M(-23.3%) |
| Dec 2019 | - | $88.07 M(-16.8%) |
| Sep 2019 | $105.81 M(+546.4%) | $105.81 M(-4.8%) |
| Jun 2019 | - | $111.16 M(-16.6%) |
| Mar 2019 | - | $133.30 M(-21.3%) |
| Dec 2018 | - | $169.45 M(+935.2%) |
| Sep 2018 | $16.37 M(-29.3%) | $16.37 M(+46.9%) |
| Jun 2018 | - | $11.14 M(-16.1%) |
| Mar 2018 | - | $13.28 M(-26.3%) |
| Dec 2017 | - | $18.02 M(-22.2%) |
| Sep 2017 | $23.16 M(-30.2%) | $23.16 M(-9.3%) |
| Jun 2017 | - | $25.54 M(-23.8%) |
| Mar 2017 | - | $33.54 M(-28.7%) |
| Dec 2016 | - | $47.05 M(+41.9%) |
| Sep 2016 | $33.15 M(+46.4%) | $33.15 M(+27.0%) |
| Jun 2016 | - | $26.11 M(+26.2%) |
| Mar 2016 | - | $20.68 M(+8.8%) |
| Dec 2015 | - | $19.01 M(-16.0%) |
| Sep 2015 | $22.65 M(+34.5%) | $22.65 M(+56.8%) |
| Jun 2015 | - | $14.45 M(-20.5%) |
| Mar 2015 | - | $18.18 M(+10.7%) |
| Dec 2014 | - | $16.43 M(-2.4%) |
| Sep 2014 | $16.83 M(+45.2%) | $16.83 M(+55.6%) |
| Jun 2014 | - | $10.82 M(-17.5%) |
| Mar 2014 | - | $13.10 M(+11.2%) |
| Dec 2013 | - | $11.78 M(+1.6%) |
| Sep 2013 | $11.59 M(+50.2%) | $11.59 M(+41.7%) |
| Jun 2013 | - | $8.18 M(-5.5%) |
| Mar 2013 | - | $8.66 M(+13.5%) |
| Dec 2012 | - | $7.63 M(-1.2%) |
| Sep 2012 | $7.72 M | $7.72 M(-4.0%) |
| Jun 2012 | - | $8.04 M(-5.6%) |
| Mar 2012 | - | $8.51 M(+16.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | - | $7.31 M(+120.0%) |
| Sep 2011 | $3.32 M(-22.3%) | $3.32 M(+22.2%) |
| Jun 2011 | - | $2.72 M(-9.8%) |
| Mar 2011 | - | $3.01 M(-61.8%) |
| Dec 2010 | - | $7.90 M(+84.8%) |
| Sep 2010 | $4.28 M(+50.3%) | $4.28 M(-16.8%) |
| Jun 2010 | - | $5.14 M(+125.5%) |
| Mar 2010 | - | $2.28 M(-11.6%) |
| Dec 2009 | - | $2.58 M(-9.3%) |
| Sep 2009 | $2.84 M(-42.6%) | $2.84 M(-36.6%) |
| Jun 2009 | - | $4.48 M(-54.1%) |
| Mar 2009 | - | $9.76 M(-6.0%) |
| Dec 2008 | - | $10.39 M(+109.8%) |
| Sep 2008 | $4.95 M(+45.8%) | $4.95 M(+62.1%) |
| Jun 2008 | - | $3.06 M(+9.4%) |
| Mar 2008 | - | $2.79 M(+0.4%) |
| Dec 2007 | - | $2.78 M(-18.0%) |
| Sep 2007 | $3.40 M(+16.3%) | $3.40 M(+15.5%) |
| Jun 2007 | - | $2.94 M(+156.5%) |
| Mar 2007 | - | $1.15 M(+12.9%) |
| Dec 2006 | - | $1.02 M(-65.2%) |
| Sep 2006 | $2.92 M(+185.1%) | $2.92 M(+68.9%) |
| Jun 2006 | - | $1.73 M(-33.2%) |
| Mar 2006 | - | $2.59 M(+77.8%) |
| Dec 2005 | - | $1.46 M(+42.2%) |
| Sep 2005 | $1.02 M(+48.5%) | $1.02 M(+3.2%) |
| Jun 2005 | - | $992.70 K(+71.4%) |
| Mar 2005 | - | $579.20 K(+64.6%) |
| Dec 2004 | - | $351.90 K(-49.0%) |
| Sep 2004 | $689.70 K(+616.9%) | $689.70 K(+84.9%) |
| Jun 2004 | - | $373.00 K(+871.4%) |
| Mar 2004 | - | $38.40 K(+89.2%) |
| Dec 2003 | - | $20.30 K(-78.9%) |
| Sep 2003 | $96.20 K(-94.0%) | $96.20 K(-94.7%) |
| Jun 2003 | - | $1.80 M(+3.2%) |
| Mar 2003 | - | $1.74 M(+6.1%) |
| Dec 2002 | - | $1.64 M(+1.8%) |
| Sep 2002 | $1.61 M(+19.5%) | $1.61 M(+2.7%) |
| Jun 2002 | - | $1.57 M(+10.0%) |
| Mar 2002 | - | $1.43 M(+0.8%) |
| Dec 2001 | - | $1.42 M(+4.8%) |
| Sep 2001 | $1.35 M(+13.1%) | $1.35 M(+3.8%) |
| Jun 2001 | - | $1.30 M(+2.5%) |
| Mar 2001 | - | $1.27 M(+3.9%) |
| Dec 2000 | - | $1.22 M(+2.3%) |
| Sep 2000 | $1.19 M(+10.7%) | $1.19 M(-2.9%) |
| Jun 2000 | - | $1.23 M(+4.7%) |
| Mar 2000 | - | $1.18 M(+4.6%) |
| Dec 1999 | - | $1.12 M |
| Sep 1999 | $1.08 M(-62.6%) | - |
| Sep 1998 | $2.88 M(+7.4%) | - |
| Sep 1997 | $2.68 M | - |
FAQ
- What is Arrowhead Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals annual total liabilities year-on-year change?
- What is Arrowhead Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals quarterly total liabilities year-on-year change?
What is Arrowhead Pharmaceuticals annual total liabilities?
The current annual total liabilities of ARWR is $948.74 M
What is the all time high annual total liabilities for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high annual total liabilities is $948.74 M
What is Arrowhead Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, ARWR annual total liabilities has changed by +$470.35 M (+98.32%)
What is Arrowhead Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of ARWR is $948.74 M
What is the all time high quarterly total liabilities for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high quarterly total liabilities is $948.74 M
What is Arrowhead Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, ARWR quarterly total liabilities has changed by +$488.99 M (+106.36%)